210
transplantation for age-related macular degeneration secondary
to extensive subfoveal scarring. Ophthalmic Surg 1991; 22 (2):
102-108.
54. Stanga PE, Kychenthal A, Fitzke FW, Halfyard AS, Chan R, Bird
AC, Aylward GW. Retinal pigment epithelium translocation after
choroidal neovascular membrane removal in age-related macular
degeneration. Ophthalmology 2002; 109 (8): 1492-1498.
55. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-
term results of submacular surgery combined with macular
translocation of the retinal pigment epithelium in neovascular
age-related macular degeneration. Ophthalmology 2005; 112
(12): 2081-2087.
56. van Meurs JC, Van Den Biesen PR. Autologous retinal pigment
epithelium and choroid translocation in patients with exudative
age-related macular degeneration: short-term follow-up. Am J
Ophthalmol 2003; 136 (4): 688-695.
57. MacLaren RE, Uppal GS, Balaggan KS et al. RPE Patch Graft
Auto-Transplantation in Macular Degeneration: A Prospective
Cohort Study. ARVO. Fort Lauderdale, USA, Apr 30-May 4,
2006. 2006; E-Abstract 2693.
58. Joussen AM, Heussen FM, Joeres S, Llacer H, Prinz B,
Rohrschneider K, Maaijwee KJ, Van MJ, Kirchhof B. Autologous
translocation of the choroid and retinal pigment epithelium in
age-related macular degeneration. Am J Ophthalmol 2006; 142
(1): 17-30.
59. Joussen AM, Joeres S, Fawzy N, Heussen FM, Llacer H, van
Meurs JC, Kirchhof B. Autologous translocation of the choroid
and retinal pigment epithelium in patients with geographic
atrophy. Ophthalmology 2007; 114 (3): 551-560.
60. MacLaren RE, Uppal GS, Balaggan KS, Tufail A, Munro
PM, Milliken AB, Ali RR, Rubin GS, Aylward GW, da CL.
Autologous transplantation of the retinal pigment epithelium
and choroid in the treatment of neovascular age-related macular
degeneration. Ophthalmology 2007; 114 (3): 561-570.
61. Treumer F, Bunse A, Klatt C, Roider J. Autologous retinal
pigment epithelium-choroid sheet transplantation in age related
macular degeneration: morphological and functional results. Br J
Ophthalmol 2007; 91 (3): 349-353.
62. Treumer F, Klatt C, Roider J. Autologe RPE-Chorioidea-
Translokation bei exsudativer AMD. Eine Falldemonstration
10 konsekutiver Patienten. Ophthalmologe 2007; 104 (9): 795-
802.
63. Maaijwee K, Heimann H, Missotten T, Mulder P, Joussen A, Van
MJ. Retinal pigment epithelium and choroid translocation in
patients with exudative age-related macular degeneration: long-
term results. Graefes Arch Clin Exp Ophthalmol 2007; 245 (11):
1681-1689.
64. Maaijwee KJ, van Meurs JC, Kirchhof B, Mooij CM, Fischer JH,
Mackiewicz J, Kobuch K, Joussen AM. Histological evidence for
revascularisation of an autologous retinal pigment epithelium--
choroid graft in the pig. Br J Ophthalmol 2007; 91 (4): 546-550.
65. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic
of visual outcome in patients with subretinal hemorrhage. Am J
Ophthalmol 1990; 109 (1): 33-37.
66. Berrocal MH, Lewis ML, Flynn HW, Jr. Variations in the clinical
course of submacular hemorrhage. Am J Ophthalmol 1996; 122
(4): 486-493.
67. Glatt H, Machemer R. Experimental subretinal hemorrhage in
rabbits. Am J Ophthalmol 1982; 94 (6): 762-773.
68. Toth CA, Morse LS, Hjelmeland LM, Landers MB, III. Fibrin
directs early retinal damage after experimental subretinal
hemorrhage. Arch Ophthalmol 1991; 109 (5): 723-729.
69. Heriot WJ. Further experience in management of submacular
hemorrhage with intravitreal tPA. Proceedings of the 1997Update
on Macular Surgery, American Academy of Ophthalmology. San
Francisco, USA, October. 1997; 82-84.
70. Hesse L, Schmidt J, Kroll P. Management of acute submacular
hemorrhage using recombinant tissue plasminogen activator and
gas. Graefes Arch Clin Exp Ophthalmol 1999; 237 (4): 273-277.
71. Karlsson E, Carlsson J, Crafoord S, Jemt M, Martensson PA,
Stenkula S. Tissue Plasminogen Activator and Expanding
Gas Intravitreally in Treatment of Submacular Hemorrhage.
Transactions of the Swedish Society of Ophthalmology 1997.
Annual Meeting. Sundsvall, Sweden, August 27-30, 1997. Acta
Ophthalmol Scand 1999; 77 (1): 119.
72. Hassan AS, Johnson MW, Schneiderman TE, Regillo CD,
Tornambe PE, Poliner LS, Blodi BA, Elner SG. Management of
submacular hemorrhage with intravitreous tissue plasminogen
activator injection and pneumatic displacement. Ophthalmology
1999; 106 (10): 1900-1906.
73. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens
TS. Treatment of submacular hemorrhage with low-dose
intravitreal tissue plasminogen activator injection and pneumatic
displacement. Arch Ophthalmol 2001; 119 (1): 28-32.
74. Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous
injection of tissue plasminogen activator and gas in the
treatment of submacular hemorrhage under various conditions.
Ophthalmology 2001; 108 (8): 1485-1492.
75. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic
displacement of subretinal hemorrhage without tissue
plasminogen activator. Arch Ophthalmol 1998; 116 (10): 1326-
1332.
76. Daneshvar H, Kertes PJ, Leonard BC, Peyman GA. Management
of submacular hemorrhage with intravitreal sulfur hexafluoride: a
pilot study. Can J Ophthalmol 1999; 34 (7): 385-388.
77. Kamei M, Misono K, Lewis H. A study of the ability of tissue
plasminogen activator to diffuse into the subretinal space after
intravitreal injection in rabbits. Am J Ophthalmol 1999; 128 (6):
739-746.
78. Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Cox TA, Toth
CA, Fekrat S, Postel EA. Pars plana vitrectomy, subretinal
injection of tissue plasminogen activator, and fluid-gas exchange
for displacement of thick submacular hemorrhage in age-related
macular degeneration. Am J Ophthalmol 2001; 131 (2): 208-
215.
79. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.
Subretinal recombinant tissue plasminogen activator injection
and pneumatic displacement of thick submacular hemorrhage in
Age-Related macular degeneration. Ophthalmology 2004; 111
(6): 1201-1208.
